Cambridge Healthtech Institute’s 8th Annual

Cell Therapy Manufacturing

Scaling and Industrializing Cell-Based Therapies

August 17- 18, 2022

CHI’s Cell Therapy Manufacturing meeting examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automation, closed systems, artificial intelligence, supply chain and facility design. The meeting will feature extensive sessions on autologous and allogeneic production platforms including CAR Ts, NK cells, TCRs, TILs and IPSCs, at scale.

Coverage will include, but is not limited to:

Cell therapy manufacturing at commercial scale – what are the challenges, controlling supply chains?
Autologous manufacturing strategies
Allogeneic manufacturing strategies
Implementing automated, closed, and integrated systems – moving from small to large scale, customized vs. off the shelf
CMO strategy, centralized and de-centralized manufacturing networks
Operations and logistics
Internal versus external manufacturing
Managing manufacturing execution systems
Chain of custody
Facility design and flexibility
Supply chain security

The deadline for priority consideration is February 4.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: